Increased risk for cardiac events, hospitalization clear predictors of death.

High frequency of infections associated with islet cell autoimmunity and disease progression.

By Guest Writer David Kliff, Diabetic Investor: As we were getting ready to disembark the plane when it arrived in Lisbon I asked a long-term consultant to the diabetes industry why he comes to EASD. “I like to come here because what they have here will show up in our country in two years” was his response. Given what we witnessed at EASD there isn’t much to look forward to in 2019.

A 41-year-old patient with a BMI of 39 kg/m2 returns for a follow-up visit 3 months after initiating metformin. She is highly sensitive to her weight and has tried to implement lifestyle modifications, but is finding it difficult to make any meaningful changes in her diet or exercise routines. Her current A1C is 7.7%, with a target goal A1C<7%. In addition to discussing consideration of bariatric surgery, which drug class might you add? A. Thiazolidinedione B. Sulfonylurea C. DDP-4 inhibitor D. GLP-1 receptor agonist Follow the link to see the correct answer.

Jane Dickinson and Susan Guzman discuss the language of diabetes: why the way we talk to and about patients, and the way we listen to them, matters so much for effective disease management.

Jane Dickinson and Susan Guzman discuss the language of diabetes, and why the specific terms we use when discussing patients with diabetes, their behavior, and their problems, are so important.

In this Exclusive Interview, Drs. Dickinson and Guzman talk with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the importance of the use of language in the care of the diabetes patient.

In part 1 of this Exclusive Interview, Drs. Dickinson and Guzman talk with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the importance of language as it is used in reference to and when speaking with people with diabetes.

In part 2 of this Exclusive Interview, Drs. Dickinson and Guzman talk with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the psychology behind the words that are innocently spoken and share examples of problematic terminology.

In part 3 of this Exclusive Interview, Drs. Dickinson and Guzman talk with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the complications of changing the common language.